1,018
Views
0
CrossRef citations to date
0
Altmetric
Acceptance & Hesitation

A systematic review of measures of healthcare workers’ vaccine confidence

, , ORCID Icon, , , & show all
Article: 2322796 | Received 07 Dec 2023, Accepted 21 Feb 2024, Published online: 20 Mar 2024

ABSTRACT

Healthcare workers (HCW) perceptions toward vaccines influence patient and community vaccine decision making. In an era of rising vaccine hesitancy, understanding HCW vaccine confidence is critical. This systematic review aims to review instruments that have been validated to measure HCW vaccine confidence. We conducted a search in five databases in June 2023. Data was descriptively synthesized. Twelve articles describing 10 different tools were included. Most tools included dimensions or items on vaccine knowledge (n = 9), safety (n = 8), vaccine usefulness (n = 8), recommendation behavior (n = 8), and self-vaccination practice (n = 7). All, except one study, were conducted in high-income countries. There was variability in the quality of the validation process. There is limited existing literature on development and validation of tools for HCW vaccine confidence. Based on the tools currently available, the Pro-VC-Be tool is the most well validated. Further research needs to include low- and middle-income contexts.

Introduction

Vaccination plays a pivotal role in public health by reducing morbidity and mortality associated with infectious diseases and their acute and long-term manifestations.Citation1 Between 2010 and 2018, measles vaccination alone has prevented over 20 million deaths.Citation2 Among the key drivers behind vaccination success are healthcare workers (HCWs), who serve as front-line providers of immunization services.Citation3 There is substantive evidence to suggest that HCWs are the most trusted advisors and influencers of vaccine decision making among patients.Citation4–8 Some evidence suggested that low confidence in vaccines among HCWs has been associated with low uptake rates of the vaccines.Citation9,Citation10

Vaccine hesitancy is a complex phenomenon. It has been defined as a behavior in delaying or refusing a particular vaccine or vaccination generally despite availability,Citation11 or as a state of indecisiveness regarding vaccination.Citation12,Citation13 Vaccine hesitancy has been observed throughout the world in the past decade,Citation14 however, since the introduction of the COVID-19 vaccine, vaccine hesitancy has increased globally, including among HCWs.Citation15–18 For example, the coverage of diphtheria-tetanus-pertussis (DTPcv1) containing vaccines decreased by 21% between 2021 and 2022, and one of the factors impacting the drop in coverage is vaccine hesitancy.Citation19

A Strategic Advisory Group of Experts on Immunization working group on vaccine hesitancy proposed the 3Cs of vaccine hesitancy as confidence (trust in vaccines and those delivering them), complacency (low risk, not necessary to take preventative measures), and convenience (affordability and accessibility).Citation11 Terminology around vaccine hesitancy and confidence is not consistent throughout the literature, and we refer to vaccine confidence throughout this paper. In an era marked by evolving vaccine production, increased public scrutiny, and rising vaccine hesitancy, it is imperative to gain a nuanced understanding of waning vaccine confidence among HCWs.Citation20

The validation of survey tools or instruments is an essential component in measuring vaccine confidence among HCWs. Validation promotes reliable, accurate, and effective tools for measuring the complex constructs of vaccine behaviors among this important population.Citation21,Citation22 The process often involves rigorous statistical and methodological evaluation, as well as cross-cultural adaptations to ensure the tools’ appropriateness in various contexts.Citation21 Tool validation is therefore important to ensure that the data collected reflect the unique characteristics and dynamics of HCW vaccine confidence.

There has been an increase in literature on HCW’s vaccine confidence using a variety of qualitative and quantitative methods. Examining the HCW’s vaccine confidence is of particular concern due to HCWs higher risk of transmission of illness,Citation14 how their vaccine confidence influences their likelihood to recommend vaccines,Citation23 and since HCWs are trusted sources for vaccine uptake among patients.Citation7,Citation8 These factors make it important to examine HCW vaccine confidence separately from parental or general population vaccine confidence.Citation23 However, to our knowledge, there is currently no published systematic reviews on the validation of tools used to assess vaccine confidence among HCWs. Therefore, this systematic review aims to review the survey tools/instruments that have been developed and validated to measure HCW vaccine confidence. This review will provide valuable insights into the development of standardized and robust assessment measures of vaccine confidence among HCWs, which can inform more targeted interventions and policies aimed at enhancing vaccine confidence among HCWs.

Methods

This is a systematic review. The review is based on current best practices utilizing the Joanna Briggs Institute (JBI) systematic review framework.Citation24 The population, concept, context (PCC) framework was used to guide the development of our research question.Citation25 The population being HCWs; the concept tools to measure vaccine hesitancy or vaccine confidence/trust, vaccine acceptance; context including a global setting. This framework as well as the literature review culminated in the research questions: What validated tools exist to measure healthcare worker vaccine confidence/hesitancy/acceptance? No review protocol exists, and the systematic review has not been registered.

Search strategy

The PRISMA checklist and flow diagram were used to guide the search and presentation of results.Citation26 The search strategy was developed in Medline (Ovid) in collaboration with librarians at the Karolinska Institutet University Library. Medline, Web of Science, CABI: CAB Abstracts, and Global Health and Sociological Abstracts were searched, and Publicly Available Content database was used as complementary search. The last search was conducted in 2023-06-08. For each search concept Medical Subject Headings (MeSH-terms) and free text terms were identified on Medline. No language restriction was applied, and databases were searched from inception with no date restrictions. The search was then translated, in part using Polyglot Search Translator.Citation27 The strategies were peer reviewed by another librarian prior to execution. Some of the key search terms used were immunization, immunization programs, exp vaccination, exp vaccines, vaccine confidence, vaccine hesitancy, vaccine acceptance, anxiety, awareness, behavior, choice behavior, communication barriers, health knowledge, attitude, and practice, intention, health personnel, benchmarking, health care surveys, quality assurance, health care, survey and questionnaire. The full search strategy is available in Appendix A.

After running the searches in all databases, a de-publication process was done using the method described by Bramer et al.Citation28 Finally, DOIs were compared to avoid duplicate articles. For the full search strategy, any articles that assessed vaccine confidence among HCW were included, then the research team narrowed to tool development and validation during the screening process.

Eligibility criteria

We included articles that focused on measuring vaccine hesitancy/confidence/acceptance, vaccine behavior, or vaccine attitudes of HCWs. Specifically, we included peer-reviewed articles describing the tool development and validation process. The term HCWs referred to any group working with healthcare.Citation29 The articles were included if the entire target population for the validation process was focused on healthcare workers or healthcare professionals. We included healthcare students in this definition of HCWs. We excluded systematic review or an intervention study.

Selection process

We used Rayyan.ai softwareCitation30 for the screening process. After the de-duplication, one researcher (EG) screened article titles and abstracts to create a short list. Initial inclusions were articles that measure healthcare worker vaccine confidence/hesitancy/acceptance that discuss how it was measured or what tools were utilized.

Two researchers (EG and KA) did a blinded title and abstract screening, which included only articles measuring tool validation with the focus of the studies’ results and discussions on how vaccine confidence was measured. From there, the articles were re-blinded and then full articles were screened using the eligibility criteria by EG and KA. Any discrepancies were discussed between EG, KA and senior researchers from the team (SHvW and BA) to determine final inclusion. Ten articles were included for the data extraction and quality assessment.Citation25

Data extraction and quality assessment

The extraction and quality assessment were done, blinded, by EG and KA using an extraction form developed by the team. The form was developed using guidance from JBI Framework.Citation24

The QAVALS (Quality Appraisal Tool Specifically for Validation Studies) measure for instrument validation was utilized due to the focus on validation methods (Appendix B).Citation22 The tool had yes, no, or other for each of 24 items on study design and validation methods. The tool items assessed articles study designs, selection criteria, testing procedure, statistical analyses, errors, reporting, face and content validity, criterion validity, and construct validity (known groups, convergent, discriminant). Based on the questions provided and the QAVALS item description guide, the researchers assessed each article as including the item (yes), not including the item (no), or as cannot be determined, not applicable, not reported (other). In the end, based on the quality assessment alone, no articles were excluded from this process. Any disparity in the overall assessment was mediated through discussion.

Data synthesis and analysis

The extraction table was modified for clarity for the tabulation of results. Descriptive statistics were used for year of publication, country income level of study location, type of tool validated, healthcare worker type, vaccine studied, sample size, and topics/dimension assessed with the tool. A heat map was generated to examine the quality of the validation processes based on the QAVALS quality assessment tool.Citation22 Based on the ratings given by EG and KA, each article was assigned a value of 1, 0.5, or 0 based on the 24 items in the assessment tool. Additionally, we added columns to say if the study included face and content validity, criterion validity, construct validity (known group, convergent, and discriminant), and reliability. A value of 1, shown in green on the map, was rated as yes, 0 (red) indicates no (item not included) and 0.5 (light green) indicates others.

Results

Overall, 9970 articles were returned from the search, and 12 were finally included (). The most common reason for article exclusion at full text review were: not focusing on tool development/validation,Citation25 being a duplicate(1), being an abstract only(1), focusing on infection control rather than vaccination(1), aim not including HCWs(1), being a protocol(1).Citation31,Citation32 One additional article was added that was published after the last search but fit all inclusion criteria.Citation33

Figure 1. PRISMA flow diagram of article inclusionCitation26.

Figure 1. PRISMA flow diagram of article inclusionCitation26.

summarizes the aims, tools assessed, vaccines, dimensions of confidence measured by the tools, and results of the ten included articles. The majority of the articles (10/12) were published since 2013,Citation33-42 and all expect one study were conducted in high-income countries.Citation33-41,Citation43,Citation44 One study was in Malaysia, an upper middle-income country.Citation42 Slightly over half (6/12) of the studies examined all vaccines,Citation33,Citation35,Citation36,Citation41–43 four focused on influenza,Citation34,Citation38,Citation39,Citation44 one focused on COVID,Citation40 and one on HPV.Citation37 The majority (9/12) included physicians, seven included nurses,Citation34,Citation36,Citation38,Citation40–42 five included general practitioners,Citation33,Citation36,Citation41–43 three included healthcare students,Citation35,Citation39,Citation43 two included all healthcare staff (including admin),Citation34,Citation39 and one included pharmacistCitation34 as their target population during validation.

Table 1. Article summary information: title, authors, year of publication, study setting location, study aim, tool assessed, population type, sample size, and type of vaccine.

Nine of the studies developed and validated novel tools.Citation34,Citation35,Citation37–39,Citation41–44 One study was based on the Vaccine Attitudes Examination (VAX) tool,Citation40 which has been previously used for patient vaccine hesitancy, and two studies validated variations of the Health Professionals Vaccine Confidence and Behavior (Pro-VC-Be) tool.Citation33,Citation36 The tools examined different dimensions (illustrated in ) but covered many related topics. Nine of the twelve included studies assessed self-assessment of knowledge/skills of vaccination.Citation33,Citation34,Citation36,Citation38,Citation41–45 Eight include items relating to recommendation behavior,Citation33–35,Citation37,Citation38,Citation41 safety of vaccines,Citation33,Citation35–38,Citation41–43 and usefulness of vaccines.Citation33,Citation35,Citation36,Citation38–41 Seven tools gathered HCW perceptions on risk of vaccines,Citation33,Citation36,Citation38–41 six gathered self-vaccination practices,Citation33,Citation35,Citation36,Citation38,Citation39,Citation41 five included influence of peer behaviorCitation34,Citation35,Citation39,Citation42 and four gathered HCW’s sense of moral responsibility.Citation35,Citation36,Citation39,Citation42,Citation45

Figure 2. Topics covered by dimensions or items in tools presented in included articles (n =11).

Figure 2. Topics covered by dimensions or items in tools presented in included articles (n =11).

The results from the studies mostly presented valid and reliable tools, but not all of the results focused on the validation process. Among the nine studies that reported Cronbach alpha scores for reliability, they all had a final score of above 0.70 on the different dimensions (). In four of the articles, they discussed that some items needed to be removed and adapted from the survey to have a strong reliability score.Citation33,Citation39,Citation41,Citation43 Validity coefficients were presented in the four studies that conducted a criterion validity, and all found good criterion validity among finalized version.Citation33,Citation36,Citation39,Citation41 Half the studies’ results and discussions primary focus were the results of the questionnaire itself rather than the validation process.Citation34,Citation35,Citation37,Citation38,Citation40,Citation43 Out of these six studies, four found that HCWs knowledge level is linked with their behavior or attitudes about vaccines.Citation34,Citation35,Citation37,Citation38

Table 2. Article dimensions, results, validation, and limitations.

Quality of tool validation

The heat map shows that the quality of the validation processes was mixed across the ten studies. Generally, the study design was well described and appropriate for a tool validation study. Yet, six of the articles did not report a sample size calculation.Citation35,Citation37–39,Citation41,Citation43 The study sample sizes had a median of 359, but a range of 108 to 2748 participants.

There was also variability in the type of validations conducted. Three studies did all three main forms of validation: face validity, criterion validity, and construct validity.Citation33,Citation36,Citation41 Among the 12 studies that examined face validity, they generally were of good quality, and in Kadir et al. they conducted both a content and face validity separately.Citation42 As the red and light green on the heat map demonstrate, criterion and construct validity were either not conducted or of a medium quality. Four studies conducted a criterion validity utilizing vaccination behavior as the comparison,Citation33,Citation38,Citation39,Citation41 and one used the long-form Pro-VC-Be tool as the criterion for the short-form version.Citation36 None of the other studies gave a rationale for why they did not conduct a criterion validation. Majority (8/11) of the studies did examine reliability.Citation33–37,Citation40,Citation42,Citation43 The quality assessments for the articles are illustrated with a heat map in .

Figure 3. Heat map of article quality assessment and validation Process.Citation46.

Figure 3. Heat map of article quality assessment and validation Process.Citation46.

Discussion

We aimed to identify and evaluate the quality of survey tools or instruments that have been validated to measure HCW vaccine confidence, hesitancy, or acceptance. We identified 10 articles that developed and conducted validation on a tool to measure HCW vaccine hesitancy or confidence.

The tools developed covered a range of dimensions and topics relating to HCW vaccine confidence using inputs from experts. However, only the three articles on the Pro-VC-Be tool clear lay out the dimension selection process.Citation33,Citation36,Citation41 Particularly, for the short-form Pro-VC-Be in which the authors ran a confirmatory factor analysis on all combination of dimensions to determine the most suitable item for each dimension. Others gave some background on the dimension and item development.Citation34,Citation35,Citation38–40 Tomietto, et al. used the existing VAX tool, and thus had predefined dimensions for the validation process.Citation40 Then Slaunwhite developed the items based on the Theory of Planned Behavior framework and a modified Perceived Behavior Control item.Citation39

Despite the variation in reporting of the dimension inclusion, all the studies aimed to examine the main determinants of vaccine confidence and behaviors. All the tools, except versions of Pro-VC-Be, had dimension assessing the HCWs knowledge and/or skills around vaccination. Knowledge and awareness around vaccines has been shown to be associated with positive vaccine attitudes and likelihood to vaccinate.Citation47 Dimension on attitude, behavior, and influence allows the tools to assess the 3Cs of vaccine hesitancy: confidence, complacency, and convenience.Citation11 Many of the tools also looked at attitudes toward vaccines, such as safety, effectiveness, vaccine usefulness, and moral responsibility, which all have been shown to be important factors influence confidence.Citation48,Citation49 A potentially important part of attitude is trust in vaccines or the health system, which five of the studies included as a dimension.Citation33,Citation36,Citation38,Citation40,Citation41

The Pro-VC-Be tools were the most well-validated tool identified, which was validated three times in a long-form, short-form and international adaption successfully tested in seven countries and four languages.Citation33,Citation36,Citation41 The other tools had less rigorous validation, thus it is important to ensure thorough validation processes in survey development studies. In a scoping review of validated tools to measure vaccine hesitancy from 2010 to 2019, the authors found 26 articles that mostly focused on parent perceptions of routine childhood immunizations and none on validating tools among HCWs.Citation21 The studies presented in our systematic review help to fill the gap between the validated tools on HCW vaccine confidence.Citation21,Citation41

Literature gaps

Results show while that there have been efforts to develop and validate tools, there were some key gaps in the literature and limitations with the existing studies. This, despite the fact that, HCW was identified as a core hesitant group during the COVID-19 pandemic.Citation15

Furthermore, our systematic review highlighted the limited geographical and income-level scope of existing research. Only one study, conducted in Israel,Citation37 took place outside of Europe and North America. Additionally, the data is restricted to high-income countries. This could be due to disease prioritization in the geographical area. However, this limitation hinders the generalizability of the findings and fails to account for the unique challenges and dynamics of vaccine confidence in low- and middle-income settings. A study protocol looking to validate the 5Cs scale among HCWs in South Africa was found, which would help expand the literature scope.Citation31 Grjesing et al. explain that the validation of a tool in one region does not mean that it is reliable and valid in another time, culture, and context.Citation50 Thus, to ensure comprehensive insights into this global issue, tool validation efforts should extend to other geographic regions.

All except oneCitation43 of the articles reviewed on tool development and validation for assessing vaccine hesitancy among HCWs were published in the last decade. This temporal gap suggests that while awareness of the importance of understanding HCW hesitancy toward has gained increasing attention, research on validated tools for HCW vaccine hesitancy is still emerging.Citation21,Citation51

While the findings from this study revealed that some studies showed good quality and comprehensive validity, others had gaps in the validation processes. Not conducting a criterion validity or having a limited explanation is a prominent challenge encountered during the validation process. The eight studies, that did not conduct a criterion validation, are then most reliant on the content validation and reliability. This means it could be a reliable tool but knowing if the tool is measuring the correct concept is more challenging and the only data presented for validity in these articles is the content or face validations. The lack of criterion validation could be because of lack of existing, widely recognized tools to measure vaccine hesitancy among HCWs, which makes it difficult to assess the criterion validity of new tools.Citation52,Citation53 Consequently, there is a need for the establishment of standard reference and more validation of tools specifically for HCWs contexts.Citation52,Citation53

Another limitation to the articles included is that several of the studies did not fully elaborate on the effects of the validation processes. The titles, aims, and even parts of methods centered on tool development and validation, while the discussions and conclusions in several of these studies have a primary focus on presenting the survey data.Citation34,Citation35,Citation37,Citation38,Citation40,Citation43 Thus, it was difficult for the reader to assess what changes should be made to a tool to improve validation or reliability of the tools. This highlights the importance of refocusing research efforts to place a stronger emphasis on how validation informs tool development and application to other studies.Citation21

Study design limitations

There are a few limitations to our study. First, the initial screening for short list generation was done by one researcher (EG) due to the high volume of searches returned. Second, although we did not have an English language restriction on the search, the diversity of languages meant that for two tools only one research extracted, and quality assessed the data.

Suggestions for further research

While numerous studies exist that assess vaccine hesitancy in this population, validation processes of tools/instruments to accurately measure vaccine confidence have been overlooked or addressed inadequately.Citation21,Citation51,Citation54–56 Our study highlights the necessity for further research specifically dedicated to the validation and reliability of tools designed for assessing vaccine hesitancy among HCWs and considering using existing validated tools, such as the Pro-VC-Be.Citation33,Citation37,Citation41 Alternatively, researchers should engage in full validation processes to ensure the reliability and validity of tools designed for specific contexts. If developing a new tool, researchers should consider including dimensions on knowledge, attitudes, trust in system, and vaccination behavior.

Additionally, research efforts should be expanded to encompass low- and middle-income countries is vital to gain a more inclusive understanding of different socio-economic and healthcare contexts that may present unique challenges and require tailored intervention.Citation57

Conclusion

We conclude that the Pro-VC-Be tool as the most useful for future research and can be used as a standard for criterion validation because the Pro-VC-Be underwent a robust validation process.Citation34 Additionally, our systematic review emphasizes the critical need for more culturally adapted and standardized tools for assessing vaccine hesitancy among HCWs. Addressing discrepancies in the existing research settings can significantly contribute to the understanding of HCWs vaccine hesitancy and inform targeted interventions and policies in a variety of settings.

Disclaimers

The submitted article are the research teams own and not an official position of the institution or funder.

Acknowledgments

We would like to acknowledge the Karolinska Institute Librarians (Narcisa Hannerz) who supported search strategy and conducted the search and duplicate deletion process in collaboration with the research team.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

This project was supported by The Swedish Research Council [2022-00756].

References

  • World Health Organization. Vaccines and immunization. World Health Organization; 2023 [accessed 2023 Oct 23]. https://www.who.int/health-topics/vaccines-and-immunization#tab=tab_1.
  • Patel MK, Dumolard L, Nedelec Y, Sodha SV, Steulet C, Gacic-Dobo M, Kretsinger K, McFarland J, Rota PA, Goodson JL. Progress toward regional measles elimination — worldwide, 2000–2018. MMWR Morb Mortal Wkly Rep. 2019 Dec 6;68(48):1105–17. doi:10.15585/mmwr.mm6848a1.
  • Agha S, Chine A, Lalika M, Pandey S, Seth A, Wiyeh A, Seng A, Rao N, Badshah A. Drivers of COVID-19 vaccine uptake amongst Healthcare Workers (HCWs) in Nigeria. Nato Adv Sci Inst Se. 2021 [accessed 2023 Oct 23];9(10):1162. doi:10.3390/vaccines9101162.
  • Paterson P, Meurice F, Stanberry LR, Glismann S, Rosenthal SL, Larson HJ. Vaccine hesitancy and healthcare providers. Vaccine. 2016 Dec 20;34(52):6700–6. doi:10.1016/j.vaccine.2016.10.042.
  • Shen AK, Browne S, Srivastava T, Michel JJ, Tan ASL, Kornides ML. Factors influencing parental and individual COVID-19 vaccine decision making in a pediatric network. Vaccines (Basel). 2022 Aug 8;10(8):1277. doi:10.3390/vaccines10081277.
  • Robinson E, Wilson P, Eleki B, Wonodi W. Knowledge, acceptance, and hesitancy of COVID-19 vaccine among health care workers in Nigeria. MGM J Med Sci. 2021;8(2):102. doi:10.4103/mgmj.mgmj_4_21.
  • Lin C, Mullen J, Smith D, Kotarba M, Kaplan SJ, Tu P. Healthcare Providers’ vaccine perceptions, hesitancy, and recommendation to patients: a systematic review. Vaccines (Basel). 2021 Jul 1;9(7):713. doi:10.3390/vaccines9070713.
  • Hajure M, Tariku M, Bekele F, Abdu Z, Dule A, Mohammedhussein M, Tsegaye T. Attitude towards COVID-19 vaccination among healthcare workers: a systematic review. Infect Drug Resist. 2021;14:3883–97. doi:10.2147/IDR.S332792.
  • Vorsters A, Bonanni P, Maltezou HC, Yarwood J, Brewer NT, Xavier Bosch F, Hanley S, Cameron R, Franco EL, Arbyn M, et al. The role of healthcare providers in HPV vaccination programs – a meeting report. Papilloma Res. 2019 [accessed 2023 Oct 23];8:100183. doi:10.1016/j.pvr.2019.100183.
  • Mansour I, Collatuzzo G, De Pasquale V, Mirra I, Ciocan C, Godono A, Pira E, Boffetta P. Vaccination confidence among healthcare workers: results from two anamnestic questionnaires adopted in the COVID-19 and influenza campaign. Nato Adv Sci Inst Se. 2022;10(11):1835. doi:10.3390/vaccines10111835.
  • MacDonald NE. SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015 Aug;33(34):4161–4. doi:10.1016/j.vaccine.2015.04.036.
  • Larson HJ. Defining and measuring vaccine hesitancy. Nat Hum Behav. 2022 Dec 1;6(12):1609–10. doi:10.1038/s41562-022-01484-7.
  • Bussink-Voorend D, Hautvast JLA, Vandeberg L, Visser O, Hulscher MEJL. A systematic literature review to clarify the concept of vaccine hesitancy. Nat Hum Behav. 2022 Dec 1 [accessed 2023 Jul 4];6(12).1634–48. https://pubmed.ncbi.nlm.nih.gov/35995837/.
  • Verger P, Botelho-Nevers E, Garrison A, Gagnon D, Gagneur A, Gagneux-Brunon A, Dubé E. Vaccine hesitancy in health-care providers in Western countries: a narrative review. Expert Review Of Vaccines. 2022 Jul 3;21(7):909–27. doi:10.1080/14760584.2022.2056026.
  • Peterson CJ, Lee B, Nugent K. COVID-19 vaccination hesitancy among healthcare workers—A review. Vaccines (Basel). 2022 Jun 15;10(6):948. doi:10.3390/vaccines10060948.
  • Lazarus JV, Wyka K, White TM, Picchio CA, Gostin LO, Larson HJ, Rabin K, Ratzan SC, Kamarulzaman A, El-Mohandes A. A survey of COVID-19 vaccine acceptance across 23 countries in 2022. Nat Med. 2023 Feb 9;29(2):366–75. doi:10.1038/s41591-022-02185-4.
  • Babatope T, Ilyenkova V, Marais D. COVID-19 vaccine hesitancy: a systematic review of barriers to the uptake of COVID-19 vaccine among adults in Nigeria. Bull Natl Res Cent. 2023 Mar 21;47(1):45. doi:10.1186/s42269-023-01017-w.
  • Altmann DM, Douek DC, Boyton RJ. What policy makers need to know about COVID-19 protective immunity. Lancet. 2020 May;395(10236):1527–9. doi:10.1016/S0140-6736(20)30985-5.
  • Kaur G, Danovaro-Holliday MC, Mwinnyaa G, Gacic-Dobo M, Francis L, Grevendonk J, Sodha SV, Sugerman C, Wallace A. Routine vaccination coverage — worldwide, 2022. MMWR Morb Mortal Wkly Rep 2023 Oct 27 [accessed 2023 Nov 7];72(43):1155–61. https://www.cdc.gov/mmwr/volumes/72/wr/mm7243a1.htm.
  • Baral P, Ahmed T, Amor Fernandez P, Peters MA, Drouard SHP, Muhoza P, Mwinnyaa G, Mwansambo C, Nzelu C, Tassembedo M, et al. Vaccine hesitancy among healthcare workers in low- and middle-income countries during the COVID-19 pandemic: results from facility surveys across six countries. PLoS One. 2023 Jul 7;18(7):e0288124. doi:10.1371/journal.pone.0288124.
  • Oduwole EO, Pienaar ED, Mahomed H, Wiysonge CS, Casuccio A. Overview of tools and measures investigating vaccine hesitancy in a Ten year period: a scoping review. Nato Adv Sci Inst Se. 2022 [accessed 2023 Oct 23];10(8):1198. doi:10.3390/vaccines10081198.
  • Gore S, Goldberg A, Huang MH, Shoemaker M, Blackwood J. Development and validation of a quality appraisal tool for validity studies (QAVALS). Physiother Theory Pract. 2021;37(5):646–54. doi:10.1080/09593985.2019.1636435.
  • Karlsson LC, Lewandowsky S, Antfolk J, Salo P, Lindfelt M, Oksanen T, Kivimäki M, Soveri A. The association between vaccination confidence, vaccination behavior, and willingness to recommend vaccines among Finnish healthcare workers. PLoS One. 2019 Oct 31;14(10):e0224330. doi:10.1371/journal.pone.0224330.
  • Santos WMD, Secoli SR, Püschel VADA. The Joanna Briggs Institute approach for systematic reviews. Rev Latino-Am Enfermagem. 2018 Nov 14;26. doi:10.1590/1518-8345.2885.3074.
  • Peters MDJ, Marnie C, Tricco AC, Pollock D, Munn Z, Alexander L, McInerney P, Godfrey CM, Khalil H. Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth. 2020 Oct;18(10):2119–26. doi:10.11124/JBIES-20-00167.
  • Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021 Mar 29;n71. doi:10.1136/bmj.n71.
  • Clark JM, Sanders S, Carter M, Honeyman D, Cleo G, Auld Y, Booth D, Condron P, Dalais C, Bateup S, et al. Improving the translation of search strategies using the polyglot search Translator: a randomized controlled trial. J Med Libr Assoc. 2020 Apr 1;108(2). doi:10.5195/jmla.2020.834.
  • Bramer WM, Giustini D, de Jonge GB, Holland L, Bekhuis T. De-duplication of database search results for systematic reviews in EndNote. J Med Libr Assoc. 2016 Jul;104(3):240–3. doi:10.3163/1536-5050.104.3.014.
  • OSHA (Occupational Safety and Health Administration). Healthcare - overview. US Department of Labor; 2023 [accessed 2023 Oct 15]. https://www.osha.gov/healthcare.
  • Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. doi:10.1186/s13643-016-0384-4.
  • Alobwede SM, Katoto PDMC, Cooper S, Lumngwena EN, Kidzeru EB, Goliath R, Jackson A, Wiysonge CS, Shey MS. Cross-cultural adaptation and validation of the 5C scale to identify factors associated with COVID-19 and influenza vaccine hesitancy among healthcare workers in Cape Town, South Africa – a protocol. F1000Res. 2022;11. doi:10.12688/f1000research.123332.1.
  • Duerink DO, Hadi U, Lestari ES, Roeshadi D, Wahyono H. A tool to assess knowledge, attitude and behavior of Indonesian health care workers regarding infection control. Indones J Int Med. 2013. https://www.inaactamedica.org/.
  • Garrison A, Karlsson L, Fressard L, Fasce A, Rodrigues F, Schmid P, Taubert F, Holford D, Lewandowsky S, Nynäs P, et al. International adaptation and validation of the pro-VC-Be: measuring the psychosocial determinants of vaccine confidence in healthcare professionals in European countries. Expert Rev Vaccines. 2023;22(1):726–37. doi:10.1080/14760584.2023.2242479.
  • Fernández-Prada M, González-Cabrera J, Gil De Miguel Á, Huerta-González I, Juan R, Madrid CE. Diseño y validación de cuestionario sobre las actitudes de los profesionales sanitarios hacia la recomendación oficial de vacunción Antigripal. Rev Esp Salud Pública. 2019 [accessed 2023 Aug 17];93. https://www.msc.es//resp.
  • Fernández-Prada M, Ramos-Martín P, Madroñal-Menéndez J, Martínez-Ortega C, González-Cabrera J, Joaquín González-Cabrera C. Diseño y validación de un cuestionario sobre vacunación en estudiantes de ciencias de salud. Rev Esp Salud Pública. 2016 [accessed 2023 Aug 17];90. https://www.msc.es/resp.
  • Garrison A, Fressard L, Karlsson L, Soveri A, Fasce A, Lewandowsky S, Schmid P, Gagneur A, Dubé E, Verger P, et al. Measuring psychosocial determinants of vaccination behavior in healthcare professionals: validation of the Pro-VC-Be short-form questionnaire. Expert Rev Vaccines. 2022 [accessed 2023 Aug 17];21(10):1505–14. doi:10.1080/14760584.2022.2108800.
  • Khamisy-Farah R, Adawi M, Jeries-Ghantous H, Bornstein J, Farah R, Bragazzi NL, Odeh M. Knowledge of human papillomavirus (HPV), attitudes and practices towards anti-HPV vaccination among Israeli pediatricians, gynecologists, and internal medicine doctors: development and validation of an ad hoc questionnaire. Vaccines (Basel). 2019 [accessed 2023 Aug 28];7(4):157. https://www.mdpi.com/journal//vaccines.
  • Paoli S, Lorini C, Puggelli F, Sala A, Grazzini M, Paolini D, Bonanni P, Bonaccorsi G. Assessing vaccine hesitancy among healthcare workers: a cross-sectional study at an Italian paediatric hospital and the development of a healthcare worker’s vaccination compliance index. Vaccines (Basel). 2019 [accessed 2023 Aug 17];7(4):201. https://www.mdpi.com//journal/vaccines.
  • Slaunwhite JM. Assessing the predictive validity of psychosocial factors on influenza vaccine acceptance among health care workers: a multi-study design. Saint Mary’s University; 2012.
  • Tomietto M, Comparcini D, Simonetti V, Papappicco CAM, Stefanizzi P. Attitudes toward COVID-19 vaccination in the nursing profession: validation of the Italian version of the VAX scale and descriptive study. Ann Ig. 2022 [accessed 2023 Aug 17];34(5):572–84. https://www.annali-igiene.it.
  • Verger P, Fressard L, Soveri A, Dauby N, Fasce A, Karlsson L, Lewandowsky S, Schmid P, Dubé E, Gagneur A. An instrument to measure psychosocial determinants of health care professionals’ vaccination behavior: validation of the Pro-VC-Be questionnaire. Expert Review Of Vaccines. 2022 [accessed 2023 Aug 17];21(5):693–709. doi:10.1080/14760584.2022.2046467.
  • Abdul Kadir A, Noor NM, Mukhtar AF. Development and validation of the knowledge and attitude regarding childhood vaccination (KACV) questionnaire among healthcare workers: the Malay version. Hum Vaccin Immunother. 2021;17(12):5196–204. doi:10.1080/21645515.2021.1989915.
  • Prislin R, Nader PR, De Guire M, Hoy PL, Pung MA. Physicians’ immunization knowledge, attitudes, and practices a valid and internally consistent measurement tool. Am J Prev Med. 1999;17(2):151–2. doi:10.1016/S0749-3797(99)00054-9.
  • Zhang J, While AE, Norman IJ. Development and testing of an instrument to assess nurses’ knowledge, risk perception, health beliefs and behaviours related to influenza vaccination. J Clin Nurs. 2012 Sep 25;21(17–18):2636–46. doi:10.1111/j.1365-2702.2011.03794.x.
  • Khamisy-Farah R, Endrawis M, Odeh M, Tuma R, Riccò M, Chirico F, Bragazzi NL. Knowledge of human papillomavirus (HPV), attitudes, and practices towards anti-HPV vaccination among Israeli nurses. J Canc Educ. 2023 Aug1 [accessed 2023 Aug 17];38(4):1391–6. doi:10.1007/s13187-023-02281-0.
  • Datylon. Datylon Report Studios. Datylon R56; 2023.
  • Herzog R, Álvarez-Pasquin MJ, Díaz C, Del Barrio JL, Estrada JM, Gil Á. Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? a systematic review. BMC Public Health. 2013 Feb19 [accessed 2023 Nov 9];13(1):1–17. doi:10.1186/1471-2458-13-154.
  • Badur S, Ota M, Öztürk S, Adegbola R, Dutta A. Vaccine confidence: the keys to restoring trust. Hum Vaccines Immunother. 2020 [accessed 2023 Nov 2];16(5):1007–1017. doi:10.1080/21645515.2020.1740559.
  • de Figueiredo A, Simas C, Karafillakis E, Paterson P, Larson HJ. Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study. Lancet. 2020 Sep 26 [accessed 2023 Nov 9];396(10255):898–908. doi:10.1016/S0140-6736(20)31558-0.
  • Gjersing L, Caplehorn JR, Clausen T. Cross-cultural adaptation of research instruments: language, setting, time and statistical considerations. BMC Med Res Methodol. 2010 Feb10 [accessed 2023 Nov 29];10(1):1–0. doi:10.1186/1471-2288-10-13.
  • Larson HJ, Jarrett C, Schulz WS, Chaudhuri M, Zhou Y, Dube E, Schuster M, MacDonald NE, Wilson R. Measuring vaccine hesitancy: the development of a survey tool. Vaccine. 2015 Aug;33(34):4165–75. doi:10.1016/j.vaccine.2015.04.037.
  • McDonald MP. Validity, data sources. Encycl Soc Meas. 2004 Jan 1;3:939–48.
  • Fink A. Survey research methods. In: Penelope P, Baker E, McGaw B, editors. International encyclopedia of education. 3rd Amsterdam (Netherlands): Elsevier Ltd; 2009. p. 152–60.
  • Soon R, Rose M, Dela I, Drph C, Tsark JU. A survey of physicians’ attitudes and practices about the human papillomavirus (HPV) vaccine in Hawaiʻi. Hawaiʻi J Med Public Health. 2015;74:234–241.
  • Jaoude JA, Saad H, Farha L, Dagher H, Khair D, Kaafarani MA, Jamaluddine Z, Cherfan P. Barriers, attitudes and clinical approach of Lebanese physicians towards HPV vaccination; a cross- sectional study. Asian Pac J Cancer Prev. 2019;20(10):3181–7. doi:10.31557/APJCP.2019.20.10.3181.
  • Badalyan AR, Hovhannisyan M, Ghavalyan G, Ter-Stepanyan MM, Cave R, Cole J, Farlow AWK, Mkrtchyan HV. Knowledge, attitude, and practice of physicians regarding vaccinations in Yerevan, Armenia: a case study of hpv. Vaccines (Basel). 2021 Oct 1;9(10):1188. doi:10.3390/vaccines9101188.
  • Coupe N, Cotterill S, Peters S. Tailoring lifestyle interventions to low socio-economic populations: a qualitative study. BMC Public Health. 2018 Dec 3;18(1):967. doi:10.1186/s12889-018-5877-8.

Appendix A

Appendix 1. Full search strategy.

2. Web of Science Core Collection.

3. CABI: CAB Abstracts and Global Health.

4. Sociological abstracts.

5. Publicly Available Content Database‎.

Appendix B

QAVALs quality assessment tool with researcher ratings for included articles.